Hematology TimesFDA approves ibrutinib as first-line CLL therapyMarch 5, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesGene therapy granted orphan designation for hemophilia AMarch 4, 2016ThrombosisPharmacy
Hematology TimesEC grants venetoclax orphan designation for AMLMarch 1, 2016Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA approves obinutuzumab for FLFebruary 27, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesOrphan designation recommended for BTK inhibitorFebruary 26, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesAdjunct T-cell therapy granted orphan designationFebruary 24, 2016PharmacyTransplantation
Hematology TimesDrug granted breakthrough designation for AMLFebruary 20, 2016Leukemia, Myelodysplasia, TransplantationPharmacyAML
